Cargando…
A multicenter, open-label, phase III study of Abcertin in Gaucher disease
BACKGROUND: Gaucher disease (GD) is caused by a deficiency in the lysosomal enzyme glucocerebrosidase. Enzyme replacement therapy (ERT) is recommended for clinical improvement. METHODS: The efficacy and safety of a new imiglucerase, Abcertin, were assessed in 7 Egyptian patients with treatment-naïve...
Autores principales: | Lee, Beom Hee, Abdalla, Ahmed Fathy, Choi, Jin-Ho, Beshlawy, Amal El, Kim, Gu-Hwan, Heo, Sun Hee, Megahed, Ahmed Megahed Hassan, Elsayed, Mona Abdel Latif, Barakat, Tarik El-Sayed Mohammad, Eid, Khaled Mohamed Abd El-Azim, El-Tagui, Mona Hassan, Mahmoud, Mona Mohamed Hamdy, Fateen, Ekram, Park, June-Young, Yoo, Han-Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690733/ https://www.ncbi.nlm.nih.gov/pubmed/29137040 http://dx.doi.org/10.1097/MD.0000000000008492 |
Ejemplares similares
-
Type I Gaucher disease with bullous pemphigoid and Parkinson disease: A case report
por: Le Peillet, Damien, et al.
Publicado: (2018) -
Comprehensive assessment of neurocognitive function, inflammation markers, and adiposity in treated HIV and control
por: Mouchati, Christian, et al.
Publicado: (2022) -
Life-threatening bleeding from gastric mucosal angiokeratomas during anticoagulation: A case report of Fabry disease
por: Kang, Eungu, et al.
Publicado: (2017) -
A multicenter, open-label, phase III study of Abcertin in Gaucher disease: Erratum
Publicado: (2018) -
A Prospective Follow-Up of Adipocytokines in Cohort Patients With Gout: Association With Metabolic Syndrome But Not With Clinical Inflammatory Findings: Strobe-Compliant Article
por: García-Méndez, Sergio, et al.
Publicado: (2015)